Drug Shortage Report for TEVA-DULOXETINE
| Report ID | 155140 |
| Drug Identification Number | 02456753 |
| Brand name | TEVA-DULOXETINE |
| Common or Proper name | DULOXETINE HCL 30MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DULOXETINE |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 blist |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-02-16 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-02-07 |
| Shortage status | Resolved |
| Updated date | 2023-02-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v23 | 2023-02-09 | French | Compare |
| v22 | 2023-02-09 | English | Compare |
| v21 | 2023-02-02 | French | Compare |
| v20 | 2023-02-02 | English | Compare |
| v19 | 2022-12-01 | French | Compare |
| v18 | 2022-12-01 | English | Compare |
| v17 | 2022-10-28 | French | Compare |
| v16 | 2022-10-28 | English | Compare |
| v15 | 2022-08-18 | French | Compare |
| v14 | 2022-08-18 | English | Compare |
| v13 | 2022-08-15 | French | Compare |
| v12 | 2022-08-15 | English | Compare |
| v11 | 2022-07-19 | French | Compare |
| v10 | 2022-07-19 | English | Compare |
| v9 | 2022-06-30 | French | Compare |
| v8 | 2022-06-30 | English | Compare |
| v7 | 2022-04-21 | French | Compare |
| v6 | 2022-04-21 | English | Compare |
| v5 | 2022-03-24 | French | Compare |
| v4 | 2022-03-24 | English | Compare |